Tade Brad L.
- SEC CIK
- 0002030561
No open-market purchases or sales filed in the past year.
Current role at each company
- ADMA Adma Biologics, Inc.CFO and Treasureras of Feb 23, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Tade Brad L. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 22, 2024 (view filing) | Nov 22 | Same day | Tade Brad L.CFO and Treasurer | SSale | −15.0K | $21.15 | −$317.3K | −7.0%199.4K after |